Navigation Links
Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results; Provides 2008 Outlook
Date:2/20/2008

,885 $1,501,251

Other revenue 30,157 8,624 92,991 15,725

Net revenue 373,890 421,384 1,501,876 1,516,976

Cost of sales 223,967 300,313 917,863 1,059,234

Gross profit 149,923 121,071 584,013 457,742

Gross margin 40.1% 28.7% 38.9% 30.2%

Research and development 25,390 26,593 102,426 83,551

Selling and marketing 13,586 13,762 55,350 52,882

Segment contribution $110,947 $80,716 $426,237 $321,309

Segment margin 29.7% 19.2% 28.4% 21.2%

Generic product sales for the fourth quarter of 2007 decreased $69.0 million to $343.7 million, primarily related to the loss of revenue from oxycodone HCl controlled-release tablets. This was offset by new product launches in 2007 of bupropion hydrochloride extended-release 300mg, fentanyl transdermal patch, and Tilia(TM) Fe.

Generic other revenue increased $21.5 million to $30.2 million, due primarily to the addition of royalties from Sandoz's sales of metoprolol succinate extended-release tablets 50mg and GlaxoSmithKline's sales of Wellbutrin XLP(R) 150mg.

Gross margin for the Generic segment increased from 29 percent in the fourth quarter 2006 to 40 percent in the fourth quarter 2007 due to the increase in other revenue, an improvement in product mix and enhanced operational efficiencies.

For the full year 2007, Generic segment product sales decreased 6 percent or $92.4 million to $1.41 billion compared to $1.50 billion for 2006, due primarily to the loss of revenue from oxycodone HCl controlled-release tablets and lower sales of pravastatin sodium tablets.

Generic other revenue increased $77.3 million to $93.0 million for 2007, due primarily to the addition of royalties from Sandoz's sales of metoprolo
'/>"/>

SOURCE Watson Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related biology technology :

1. Watson to Present at the 2008 Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
2. Warner Chilcott and Watson Pharmaceuticals Announce Launch of Tilia(TM) Fe
3. Watson Receives FDA Approval for Generic Accuneb(R)
4. Watson to Present at the Bear Stearns 20th Annual Healthcare Conference
5. Graceway Pharmaceuticals, LLC(TM) Announces Completed Acquisition of All Assets Related to Estrasorb(R) Product Line in North America From Allergan, Inc. (NYSE: AGN) and Novavax, Inc. (Nasdaq: NVAX)
6. Novavax Enters Into Estrasorb(R) Asset Sale and Supply Agreements with Graceway Pharmaceuticals, LLC
7. Boehringer Ingelheim Pharmaceuticals, Inc. Receives the NCQA Seal Of Approval
8. Onyx Pharmaceuticals Announces a Teleconference and Webcast to Provide an Update on Nexavar and Report Full Year 2007 Financial Results
9. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
10. Keryx Biopharmaceuticals Announces Additions to Management Team
11. Cadence Pharmaceuticals to Raise up to $49.3 Million in Registered Direct Common Stock Offering
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... Nueva Jersey , 22 de enero de 2015 ... Research abre hoy su llamada a nominaciones para 2015. ... científica ha hecho, o tiene el potencial para hacer, ... Las nominaciones se aceptarán hasta el 15 de marzo ...
(Date:1/22/2015)...  Derma Sciences, Inc. (Nasdaq: DSCI ), ... care, announces that AMNIOEXCEL® and AMNIOMATRIX®, amniotic allografts ... the Premier, Inc. Regenerative Skin Grafting contract portfolio. ... and AMNIOMATRIX® product lines, which continue to be ...
(Date:12/24/2014)... , Dec. 24, 2014  Vermillion, Inc. (Nasdaq: ... gynecologic disease, announced today that the Company closed ... Oracle Investment Management, Jack W. Schuler , ... proceeds were $10.5 million, before offering expenses.  The ...
(Date:12/24/2014)... Boston, MA (PRWEB) December 23, 2014 Earlier ... James L. Sherley, director of the Adult Stem Cell Technology ... overlooked and under appreciated unique property of adult tissue stem ... Misunderstood in the Past, Important for the Future,” embodied the ...
Breaking Biology Technology:El Dr. Paul Janssen Award for Biomedical Research emite su llamada a los nominados para 2015 2El Dr. Paul Janssen Award for Biomedical Research emite su llamada a los nominados para 2015 3El Dr. Paul Janssen Award for Biomedical Research emite su llamada a los nominados para 2015 4Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 2Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 3Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 4Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 5Vermillion Announces Closing of Equity Financing 2Vermillion Announces Closing of Equity Financing 3Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 2Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 3Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 4
... Sept. 28 PPD, Inc. (Nasdaq:,PPDI) will release its ... the market closes. The earnings release will be available,on ... and PR Newswire. On Wednesday, October 24, at ... and audio webcast to discuss financial results and the,overall ...
... Pa., Sept. 28 /PRNewswire-FirstCall/ - Genaera,Corporation (Nasdaq: GENR ... of Xmark Asset Management LLC ("Xmark"), to Genaera,s Board ... as Executive Vice,President and Chief Scientific Officer, and Michael ... Medical Officer. "We are pleased to add Mitch ...
... MELBOURNE, Australia, Sept. 28 Prana,Biotechnology Limited ... on the research and development of treatments ... its annual report,containing audited consolidated financial statements ... the U.S. Securities and Exchange Commission. The ...
Cached Biology Technology:PPD Announces Third Quarter 2007 Earnings Release, Webcast and Conference Call 2Genaera Elects New Board Member and Announces Executive Appointments 2Genaera Elects New Board Member and Announces Executive Appointments 3Genaera Elects New Board Member and Announces Executive Appointments 4
(Date:12/22/2014)... Dec. 22, 2014  The 2014 Holiday Season may be ... Market Intelligence reports that the long anticipated floodgates for ... intensifying demand for smart phones, tablets, and wearable mobile ... of 2.5 billion users with nearly 4.8 billion biometric ...
(Date:12/19/2014)... , Dec. 18, 2014   LaunchKey , the ... the post-password and Internet of Things era, today announced ... The venture round was led by Metamorphic Ventures with ... Venture Partners, VegasTechFund, and others.  LaunchKey has raised $4 ...
(Date:12/17/2014)... Valencell, a leader in performance biometric data sensor ... leaders such as Intel, Jabra, Atlas, and Scosche to ... These products will be showcased at CES 2015, taking ... . "Our partners choose PerformTek biometrics, ...
Breaking Biology News(10 mins):First Season of Holiday Shopping with Mobile Biometric Payments Wraps Up With a Present for Biometrics Industry: A Rosy Forecast for More Than 2 Billion Users of 4.8 Billion Mobile Biometric Devices by 2020 2LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 2LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 3Valencell PerformTek Biometrics Power the Most Accurate Wearables at CES 2015 2
... used to monitor water quality has been called into question by ... bacteria that might not indicate an environmental hazard. Fecal ... E. coli bacteria in the water because E. coli ... of humans and other warm-blooded animals, and quickly die outside its ...
... RIVERSIDE, Calif. Juicy. Extremely Sweet. Visually ... are the fine qualities that mark ,KinnowLS, the latest citrus ... Large-sized for a mandarin, the fruit has an orange ... The 10-11 segments in each fruit are fleshy and deep ...
... in a person, but in an infectious disease, it is ... host for decades before bursting forth into infection. TB,s stealthy ... seriously hampering efforts to control it. The World Health Organization ... infected. Now, a study led by Stanford scientists has ...
Cached Biology News:Study provides new way to classify E. coli bacteria and test for fecal contamination 2Study provides new way to classify E. coli bacteria and test for fecal contamination 3New citrus variety released by UC Riverside is very sweet, juicy and low-seeded 2New citrus variety released by UC Riverside is very sweet, juicy and low-seeded 3Tuberculosis strain spread by the fur trade reveals stealthy approach of epidemics 2Tuberculosis strain spread by the fur trade reveals stealthy approach of epidemics 3Tuberculosis strain spread by the fur trade reveals stealthy approach of epidemics 4
...
Peptide-affinity Purified Polyclonal Antibody to MAML1 / Mastermind Peptide with sequence VLPTCPMAEFALPR, from N Terminus of the protein sequence according to NP_055572....
Mouse monoclonal [5H9] to RAD52 ( Abpromise for all tested applications). entrezGeneID: 5893 SwissProtID: P43351...
... to the family of calcium binding proteins such ... composed of an alpha and beta chain whereas ... S100 protein is also expressed in the antigen ... skin and interdigitating reticulum cells in the paracortex ...
Biology Products: